GV1001-Gem/Cap

GV1001-Gemcitabine/Capecitabine · Samsung Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GV1001-Gem/Cap, covering 2016-11-22 to 2016-11-22. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients [Phase 3]

See pricing